Vapor for lung volume reduction; pros and cons.


Journal

Expert review of respiratory medicine
ISSN: 1747-6356
Titre abrégé: Expert Rev Respir Med
Pays: England
ID NLM: 101278196

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 2 9 2020
medline: 16 6 2021
entrez: 2 9 2020
Statut: ppublish

Résumé

Bronchoscopic lung volume reduction (BLVR) is a novel approach for treatment of emphysema. Several techniques are available to accomplish BLVR including Bronchoscopic Vapor Thermal Ablation (BVTA). This technique is easy to perform and considered safe due to its gradual effect. We discuss BTVA in detail in this editorial. We discuss our experience with BTVA in detail including patient selection, equipment, procedure, post-procedural care and complications. We also review the literature to determine the pros and cons for its use. Other modalities such as endobronchial valves, coils and lung sealants are also briefly discussed. Vapor ablation is a novel and safe approach in inducing lung volume reduction in emphysema patients. The effects are gradual, and therefore potentially making it safer than other minimally invasive modalities. Pneumonitis and infection are common side effects. Just as in other BLVR techniques, a case by case evaluation is needed to determine the right candidate for BTVA. Further larger studies are needed before BTVA becomes standard of care in treatment of patients with emphysema.

Identifiants

pubmed: 32870725
doi: 10.1080/17476348.2020.1816467
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1189-1195

Auteurs

Paul Zarogoulidis (P)

Pulmonary Department, ``Bioclinic`` Private Hospital , Thessaloniki, Greece.
3rd Department of Surgery, ``AHEPA`` University Hospital, Aristotle University of Thessaloniki, Medical School , Thessaloniki, Greece.

Wolfgang Hohenforst-Schmidt (W)

Sana Clinic Group Franken, Department of Cardiology/Pulmonology/Intensive Care/Nephrology, "Hof" Clinics, University of Erlangen , Hof, Germany.

Haidong Huang (H)

Department of Respiratory & Critical Care Medicine, Changhai Hospital, the Second Military Medical University , Shanghai, P. R. China.

Konstantinos Sapalidis (K)

Pulmonary Department, ``Bioclinic`` Private Hospital , Thessaloniki, Greece.

Christoforos Kosmidis (C)

Pulmonary Department, ``Bioclinic`` Private Hospital , Thessaloniki, Greece.

Stavros Tryfon (S)

Pulmonary Department, (NHS), ``G. Papanikolaou`` General Hospital , Thessaloniki, Greece.

Anastasios Vagionas (A)

Oncology Department, (NHS), General Hospital of Kavala , Kavala, Greece.

Kosmas Tsakiridis (K)

Thoracic Surgery Department, ``Interbalkan`` European Medical Center , Thessaloniki, Greece.

Konstantinos Drevelegas (K)

Radiology Department , ``Euromedica`` Private Laboratory , Thessaloniki, Greece.

Konstantinos Romanidis (K)

Second Department of Surgery, General University Hospital of Alexandroupolis, Medical School Democritus University of Thrace , Alexandroupolis, Greece.

Lutz Freitag (L)

Department of Pulmonology, University Hospital Zurich Rämistrasse 100, 8091 , Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH